GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Institutional Ownership

Cangene (FRA:YGE) Institutional Ownership : 83.00% (As of May. 15, 2024)


View and export this data going back to . Start your Free Trial

What is Cangene Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cangene's institutional ownership is 83.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cangene's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cangene's Float Percentage Of Total Shares Outstanding is N/A.

Cangene Institutional Ownership Historical Data

The historical data trend for Cangene's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Institutional Ownership Chart

Cangene Historical Data

The historical data trend for Cangene can be seen below:

2013-04-30 2013-05-31 2013-06-30 2013-07-31 2013-08-31 2013-09-30 2013-10-31 2013-11-30 2013-12-31 2014-01-31
Institutional Ownership 83.00 83.00 83.00 83.00 83.00 79.00 79.00 79.00 83.00 83.00

Cangene Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Cangene (FRA:YGE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Institutional Ownership
Comparable Companies
ASX:NEU OSTO:IBT B XKRX:115180 ROCO:6657 WBO:MARI XPAR:TNG CNCE ROCO:6575 EVLO ALDX HKSE:01035 XFOR GMDA MIRM TSXV:ACST XPAR:NANO OCSE:ORPHA XYNO SLGL AQST
Traded in Other Exchanges
N/A
Address
Website
http://www.cangene.com
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines